From: Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial
TCZ groupa
1
1.5
2
Placebo groupa
5.5
91.5
80
65.8
6
94.5
86.1
73.3
6.5
96.2
90
79.8